维普中文期刊产品整合服务
7篇 您的检索式:作者名="Bhatt BI"
    题名 作者 年代 出处 被引量
1Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study 显示文摘Bhatt DL Lee BI Casterella P J 2003J Am Coil Cardiol2003,41,1:1
2Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention, results of the Coronary Revascularization, Using Integrilin and Single Bolus Enoxaparin Study显示文摘Bhatt DE Lee BI Casterella PJ 2003J Am Coil Cardiol2003,41,:1
3Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study显示文摘Bhatt DL Lee BI Casterella PJ 2003J Am Coll Cardiol2003,41,1:1
4Novel method for the isolation and eharacterisation of the putative prostatic stem cell 显示文摘Bhatt BI Brown MD Hart CA 2003Cytometry2003,54,2:1
5Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study 显示文摘Bhatt DL Lee BI Casterella PJ 2003J Am Coll Cardiol2003,41,1:1
6Safety of concomitant therapy with eptifibatide and enoxaparin in patiants undergoing percutaneous coronary intervention : Resalts of the coronary revascularization using integrilin and single bolus enoxaparin stady显示文摘Bhatt DL Lee BI 2003American College of Cardiology Toundation2003,41,1:1
7Safetv of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention:results of the Coronary Revascularization Using Integrelin and Single bolus Enoxaparin study显示文摘Bhatt DL Lee BI Casterella PJ 2003J Am Coll Cardiol2003,41,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费